SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 40 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | 0.0% | 2,587 | +1.3% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 2,554 | +64.1% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 1,556 | +86.8% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 833 | -3.8% | 0.00% | – |
| Q1 2019 | $1,000 | – | 866 | +4.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 833 | -8.6% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 911 | +9.4% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 833 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | -33.3% | 833 | -1.2% | 0.00% | – |
| Q4 2017 | $3,000 | – | 843 | +8330.0% | 0.00% | – |
| Q3 2017 | $0 | – | 10 | -90.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 100 | -62.5% | 0.00% | – |
| Q3 2016 | $1,000 | – | 267 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,133,583 | $4,104,000 | 3.61% |
| GREAT POINT PARTNERS LLC | 1,537,873 | $5,567,000 | 1.14% |
| BVF INC/IL | 1,392,720 | $5,042,000 | 1.01% |
| Boxer Capital, LLC | 525,000 | $1,901,000 | 0.74% |
| Vivo Capital, LLC | 500,000 | $1,810,000 | 0.60% |
| Healthcare Value Capital, LLC | 150,000 | $543,000 | 0.58% |
| Cormorant Asset Management, LP | 1,000,000 | $3,620,000 | 0.49% |
| Telemetry Investments, L.L.C. | 120,807 | $437,000 | 0.25% |
| Palo Alto Investors LP | 1,162,473 | $4,208,000 | 0.24% |
| NEA Management Company, LLC | 1,298,274 | $4,700,000 | 0.19% |